These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32416414)

  • 21. Sodium status and kidney involvement during COVID-19 infection.
    Post A; Dullaart RPF; Bakker SJL
    Virus Res; 2020 Sep; 286():198034. PubMed ID: 32445872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
    Tan CS; Yeoh SF; Long CM
    Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
    [No Abstract]   [Full Text] [Related]  

  • 23. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.
    Debnath M; Banerjee M; Berk M
    FASEB J; 2020 Jul; 34(7):8787-8795. PubMed ID: 32525600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative ACE2 variation and primate COVID-19 risk.
    Melin AD; Janiak MC; Marrone F; Arora PS; Higham JP
    Commun Biol; 2020 Oct; 3(1):641. PubMed ID: 33110195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
    Alshahawey M; Raslan M; Sabri N
    Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration: Potential Relevance to COVID-19 Risk.
    Nelson CP; Sama IE; Codd V; Webb TR; Ye S; Lang CC; Voors AA; Ng LL; Samani NJ
    Circulation; 2020 Sep; 142(11):1117-1119. PubMed ID: 32795093
    [No Abstract]   [Full Text] [Related]  

  • 28. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.
    Chen J; Jiang Q; Xia X; Liu K; Yu Z; Tao W; Gong W; Han JJ
    Aging Cell; 2020 Jul; 19(7):. PubMed ID: 32558150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.
    Tan CW; Chia WN; Qin X; Liu P; Chen MI; Tiu C; Hu Z; Chen VC; Young BE; Sia WR; Tan YJ; Foo R; Yi Y; Lye DC; Anderson DE; Wang LF
    Nat Biotechnol; 2020 Sep; 38(9):1073-1078. PubMed ID: 32704169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
    Nawijn MC; Timens W
    Mol Syst Biol; 2020 Jul; 16(7):e9841. PubMed ID: 32715628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
    Sarode SC; Sarode GS; Gondivkar S; Gadbail A; Gopalakrishnan D; Patil S
    Oral Oncol; 2020 Aug; 107():104811. PubMed ID: 32505551
    [No Abstract]   [Full Text] [Related]  

  • 33. How does SARS-CoV-2 cause COVID-19?
    Matheson NJ; Lehner PJ
    Science; 2020 Jul; 369(6503):510-511. PubMed ID: 32732413
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
    Mittal A; Manjunath K; Ranjan RK; Kaushik S; Kumar S; Verma V
    PLoS Pathog; 2020 Aug; 16(8):e1008762. PubMed ID: 32822426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
    Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
    Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 and the next generations: which impact on reproductive tissues?
    Zupin L; Pascolo L; Zito G; Ricci G; Crovella S
    J Assist Reprod Genet; 2020 Oct; 37(10):2399-2403. PubMed ID: 32783136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin is a potential host of SARS-CoV-2: A clinical, single-cell transcriptome-profiling and histologic study.
    Sun Y; Zhou R; Zhang H; Rong L; Zhou W; Liang Y; Li Q
    J Am Acad Dermatol; 2020 Dec; 83(6):1755-1757. PubMed ID: 32822795
    [No Abstract]   [Full Text] [Related]  

  • 38. Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus.
    Qiang XL; Xu P; Fang G; Liu WB; Kou Z
    Infect Dis Poverty; 2020 Mar; 9(1):33. PubMed ID: 32209118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 40. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
    Esler M; Esler D
    J Hypertens; 2020 May; 38(5):781-782. PubMed ID: 32195824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.